Loss‐of‐function mutations or deletions in TGF‐β pathway genes, including TGF‐β receptors and SMAD genes, are frequently observed in different cancer types (Blaker et al., 2002; Massague et al., 2000). The gene discussed is TGFB1; the disease is cancer.